Neoss Limited – Trademark Portfolio
Entity Type: 99
Neoss Limited holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 18 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 14 trademarks are registered. Notable registered marks include NEOSS, NEOGEN, NEOPRO, NEOBASE, and NEOSCAN. The owner is based in North Yorkshire.
Windsor House, Cornwall Road, Harrogate
North Yorkshire HG12PW , GB
Showing of trademarks Trademarks
Trademark Classifications
Neoss Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Neoss Limited have?
Neoss Limited has 20 U.S. trademarks filed with the USPTO. Of these, 14 registered, 2 abandoned.
What trademark classes does Neoss Limited file in?
Neoss Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Neoss Limited's most well-known trademarks?
Neoss Limited's registered trademark portfolio includes well-known marks such as NEOSS, NEOGEN, NEOPRO, NEOBASE, and NEOSCAN. These are among 14 currently registered trademarks in the portfolio.
What is Neoss Limited's trademark registration success rate?
Neoss Limited has a 88% trademark registration rate, with 14 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.